ANN ARBOR STAGE III GRADE 3 FOLLICULAR LYMPHOMA

Clinical trials for ANN ARBOR STAGE III GRADE 3 FOLLICULAR LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new ANN ARBOR STAGE III GRADE 3 FOLLICULAR LYMPHOMA trials appear

Sign up with your email to follow new studies for ANN ARBOR STAGE III GRADE 3 FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 2 Completed 1

Scientists test adding a third drug to standard lymphoma treatment

Disease control Completed

This study aimed to see if adding the drug bortezomib to a standard two-drug combination (ofatumumab and bendamustine) was more effective for people newly diagnosed with a type of slow-growing blood cancer called follicular lymphoma. It involved 135 patients with high-risk diseas…

Matched conditions: ANN ARBOR STAGE III GRADE 3 FOLLICULAR LYMPHOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

ANN ARBOR STAGE III GRADE 3 FOLLICULAR LYMPHOMA

Get alerted when new ANN ARBOR STAGE III GRADE 3 FOLLICULAR LYMPHOMA trials appear

Scientists test adding a third drug to standard lymphoma treatment